Bank of America’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.9M | Sell |
451,808
-342,546
| -43% | -$2.2M | ﹤0.01% | 3723 |
|
|
2025
Q1 | $2.81M | Sell |
794,354
-1,631,909
| -67% | -$5.78M | ﹤0.01% | 3670 |
|
|
2024
Q4 | $9.17M | Buy |
2,426,263
+1,513,748
| +166% | +$5.72M | ﹤0.01% | 2581 |
|
|
2024
Q3 | $2.96M | Buy |
912,515
+434,991
| +91% | +$1.41M | ﹤0.01% | 3583 |
|
|
2024
Q2 | $907K | Buy |
477,524
+201,568
| +73% | +$383K | ﹤0.01% | 4230 |
|
|
2024
Q1 | $784K | Buy |
275,956
+155,628
| +129% | +$442K | ﹤0.01% | 4308 |
|
|
2023
Q4 | $1.77M | Buy |
120,328
+42,142
| +54% | +$620K | ﹤0.01% | 3737 |
|
|
2023
Q3 | $1.43M | Sell |
78,186
-39,025
| -33% | -$715K | ﹤0.01% | 3782 |
|
|
2023
Q2 | $2.53M | Buy |
117,211
+48,887
| +72% | +$1.05M | ﹤0.01% | 3377 |
|
|
2023
Q1 | $2M | Buy |
68,324
+4,958
| +8% | +$145K | ﹤0.01% | 3712 |
|
|
2022
Q4 | $2.34M | Buy |
63,366
+54,479
| +613% | +$2.01M | ﹤0.01% | 3539 |
|
|
2022
Q3 | $251K | Sell |
8,887
-7,683
| -46% | -$217K | ﹤0.01% | 5066 |
|
|
2022
Q2 | $319K | Buy |
16,570
+13,666
| +471% | +$263K | ﹤0.01% | 5029 |
|
|
2022
Q1 | $38K | Buy |
+2,904
| New | +$38K | ﹤0.01% | 6491 |
|